Kabasawa K, Itagaki H, Ikeda R, Shinoda T, Kagaya K, Fukazawa Y
Iatron Laboratories, Inc., Tokyo, Japan.
J Clin Microbiol. 1991 Dec;29(12):2873-6. doi: 10.1128/jcm.29.12.2873-2876.1991.
A new method for identifying Cryptococcus neoformans isolates and their serotypes by the slide agglutination test using five kinds of factor sera, with the aid of nitrate reduction, phenol oxidase, and growth at 37 degrees C tests was evaluated by using 36 reference strains and 75 clinical isolates of C. neoformans. The results showed that the reference strains were identified exactly as they were labeled, and clinical isolates were identified as C. neoformans serotypes A, D, and AD. C. neoformans could be distinguished from other Cryptococcus species that cross-reacted with factor sera by their ability to grow at 37 degrees C. These results indicate that the slide agglutination test combined the use of factor sera for isolates which grow at 37 degrees C is a useful method for identification of C. neoformans and their serotypes and that the nitrate reduction test (negative in 100% of the isolates) and the phenol oxidase test (positive in approximately 95% of the isolates) can be used to confirm that the species is C. neoformans.
通过使用五种因子血清的玻片凝集试验,并借助硝酸盐还原试验、酚氧化酶试验以及37℃生长试验,对一种鉴定新型隐球菌分离株及其血清型的新方法进行了评估,该评估使用了36株参考菌株和75株新型隐球菌临床分离株。结果显示,参考菌株被准确鉴定为其标记的类型,临床分离株被鉴定为新型隐球菌血清型A、D和AD。新型隐球菌可通过其在37℃生长的能力与其他与因子血清发生交叉反应的隐球菌物种区分开来。这些结果表明,对于在37℃生长的分离株,结合使用因子血清的玻片凝集试验是鉴定新型隐球菌及其血清型的一种有用方法,并且硝酸盐还原试验(100%的分离株为阴性)和酚氧化酶试验(约95%的分离株为阳性)可用于确认该物种为新型隐球菌。